Long-term use of investigational β-Hydroxybutyrate salts in children with multiple acyl-CoA dehydrogenase or pyruvate dehydrogenase deficiency by Andrew A.M. Morris, Bernard Cuenoud, Philippe Delerive, Helen Mundy, Bernd C. Schwahn

Get full text

Comparative genotypic and phenotypic analysis of human peripheral blood monocytes and surrogate monocyte-like cell lines commonly used in metabolic disease research. by Darren M Riddy, Emily Goy, Philippe Delerive, Roger J Summers, Patrick M Sexton, Christopher J Langmead

Get full text

A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease by Adel Hammoutene, Samira Laouirem, Miguel Albuquerque, Nathalie Colnot, Angélique Brzustowski, Dominique Valla, Nicolas Provost, Philippe Delerive, Valérie Paradis

Get full text

Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice by Klaus Seedorf, Csaba Weber, Cedric Vinson, Sylvie Berger, Laurent-Michel Vuillard, Arpad Kiss, Stephanie Creusot, Olivier Broux, Anne Geant, Catherine Ilic, Karine Lemaitre, Johann Richard, Adel Hammoutene, Julien Mahieux, Virginie Martiny, Didier Durand, Fabien Melchiore, Miklos Nyerges, Valerie Paradis, Nicolas Provost, Valérie Duvivier, Philippe Delerive

Get full text